Adelard Kakunze: Changing the Future of Sickle Cell Disease in Africa
Adelard Kakunze, Senior Technical Officer – NCDs, Injuries and Mental Health at Africa Centres for Disease Control and Prevention (Africa CDC), shared a post on LinkedIn:
”The validation of the Africa CDC Continental Plan for Sickle Cell Disease and Other Inherited Blood Disorders is deeply personal to me.
For years, I have witnessed the immense physical pain, emotional distress, and financial hardship that children living with sickle cell disease (SCD) and their families endure across Africa.
Yet Africa continues to carry the world’s highest burden, with the majority of the 300,000+ babies born annually with SCD globally born on the continent, while up to 90% of affected African children still die before age five.
From 11–13 May in Kampala, 50 African Union Member States united behind one continental plan to change this narrative as we advance the Africa Health Security and Sovereignty Agenda.
This Plan moves us beyond fragmented pilot projects toward coordinated, scalable, and evidence-based interventions that save lives with ambitious targets by 2035, including screening 70% of newborns and ensuring that at least 90% of children with SCD survive beyond age five.
Just days after we left Uganda, the country reported its first Ebola case, a reminder that Africa faces multiple public health threats at once.
Yet Uganda and the DRC have repeatedly demonstrated strong leadership in managing outbreaks, and I have no doubt they will respond effectively once again while we continue strengthening systems for both emergencies and long-neglected conditions like SCD and other inherited blood disorders.”
Stay updated with Hemostasis Today.
-
Aug 27, 2026, 11:08Sunisha Arora: New EBMT Recommendations Transform the Approach to HSCT in Thalassemia
-
Aug 27, 2026, 10:51Seema Dawood: A Layered Approach to Identifying Thalassemia in the Laboratory
-
Aug 27, 2026, 10:44Ed Smith: Vitalant Expands Hemophilia Center Team With New Career Opportunities
-
Aug 27, 2026, 10:43FDA Expands Hympavzi Approval to Children and Patients With Hemophilia A or B With Inhibitor
-
Aug 27, 2026, 10:28Narat Srivali: Exploring the Link Between Perioperative Corticosteroids and VTE Risk
-
Aug 27, 2026, 10:19Vincent Poher: Clinical Validation of Rapid Whole-Blood Fibrinogen Measurement
-
Aug 27, 2026, 07:49Denis Oduor: Bringing Blood Closer – Strengthening Kenya’s Response to PPH
-
Aug 27, 2026, 07:19Luis Oliverio Ambriz Garcia: ASH 2026 Guidelines – What’s New in ITP?
-
Aug 27, 2026, 06:58Priyam Bordoloi: The Biological Advantage of Two X Chromosomes